(EGRX) Eagle Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eagle Pharmaceuticals | (EGRX) share price targets
Complete technical analysis of Eagle Pharmaceuticals (EGRX) by charts plus indicators, forecast predictions and share price targets for Eagle Pharmaceuticals (EGRX)
Eagle Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-23 View latest technical analysis
10 day averaged volume of Eagle Pharmaceuticals is 89220
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 3.90 | 4.01 | 4.14 | 3.73 | 1.117 times |
| 20 Fri Sep 2024 | 3.96 | 4.23 | 4.26 | 3.83 | 2.089 times |
| 19 Thu Sep 2024 | 4.27 | 4.44 | 4.54 | 4.27 | 0.38 times |
| 18 Wed Sep 2024 | 4.28 | 4.42 | 4.57 | 4.15 | 0.551 times |
| 17 Tue Sep 2024 | 4.43 | 4.29 | 4.50 | 4.05 | 0.572 times |
| 16 Mon Sep 2024 | 4.23 | 4.44 | 4.44 | 4.02 | 0.308 times |
| 13 Fri Sep 2024 | 4.31 | 3.91 | 4.87 | 3.91 | 2.462 times |
| 12 Thu Sep 2024 | 3.83 | 3.73 | 3.91 | 3.55 | 1.256 times |
| 11 Wed Sep 2024 | 3.73 | 3.86 | 3.98 | 3.60 | 0.425 times |
| 10 Tue Sep 2024 | 3.83 | 3.91 | 3.91 | 3.77 | 0.865 times |
Share price targets for Eagle Pharmaceuticals (EGRX)
| Target Type | Value |
| Downside Target | 3.21 |
| Downside Target | 3.30 |
| Downside Target | 3.55 |
| Downside Target | 3.73 |
| Downside Target | 3.83 |
| Upside Target | 4.13 |
| Upside Target | 4.57 |
| Upside Target | 4.87 |
| Upside Target | 4.98 |
| Upside Target | 5.12 |
| Upside Target | 5.14 |
| Upside Target | 5.26 |
| Upside Target | 5.45 |
| Upside Target | 5.60 |
| Upside Target | 6.37 |
Intraday share price targets for Eagle Pharmaceuticals (EGRX)
| Target Type | Value |
| Downside Intraday Target | 3.71 |
| Downside Intraday Target | 3.51 |
| Upside Intraday Target | 4.12 |
| Upside Intraday Target | 4.33 |
| Upside Intraday Target | 3.92 |
Weekly technical analysis of Eagle Pharmaceuticals (EGRX)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 3.90 | 4.01 | 4.14 | 3.73 | 0.286 times |
| 20 Fri Sep 2024 | 3.96 | 4.44 | 4.57 | 3.83 | 0.639 times |
| 13 Fri Sep 2024 | 4.31 | 4.28 | 4.87 | 3.55 | 1.264 times |
| 06 Fri Sep 2024 | 4.25 | 5.11 | 5.14 | 4.13 | 8.034 times |
| 30 Fri Aug 2024 | 5.14 | 5.26 | 5.26 | 5.12 | 0.121 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Eagle Pharmaceuticals (EGRX)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Mon Sep 2024 | 3.90 | 5.11 | 5.14 | 3.55 | 0.734 times |
| 30 Fri Aug 2024 | 5.14 | 4.83 | 5.45 | 3.87 | 0.634 times |
| 31 Wed Jul 2024 | 4.82 | 5.65 | 6.37 | 4.65 | 0.676 times |
| 28 Fri Jun 2024 | 5.60 | 3.47 | 5.60 | 3.30 | 1.299 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Eagle Pharmaceuticals (EGRX)
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eagle Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Eagle Pharmaceuticals in short term and the sell signal is strong.
Eagle Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Eagle Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eagle Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.07 and Eagle Pharmaceuticals (EGRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eagle Pharmaceuticals (EGRX) stock. Volume based technical analysis of Eagle Pharmaceuticals (EGRX) stock is negative.
Eagle Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Eagle Pharmaceuticals ( (EGRX) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eagle Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Eagle Pharmaceuticals in short term and the sell signal is strong.
Eagle Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Eagle Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Eagle Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.07 and Eagle Pharmaceuticals (EGRX) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eagle Pharmaceuticals (EGRX) stock. Volume based technical analysis of Eagle Pharmaceuticals (EGRX) stock is negative.
Eagle Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.